Allspring Global Investments’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,923
Closed -$198K 2701
2023
Q3
$198K Buy
4,923
+173
+4% +$8.1K ﹤0.01% 1765
2023
Q2
$250K Buy
4,750
+48
+1% +$2.92K ﹤0.01% 1740
2023
Q1
$301K Sell
4,702
-325
-6% -$21.2K ﹤0.01% 1720
2022
Q4
$244K Sell
5,027
-61
-1% -$3.83K ﹤0.01% 1781
2022
Q3
$358K Sell
5,088
-682
-12% -$58.4K ﹤0.01% 1660
2022
Q2
$409K Sell
5,770
-21,958
-79% -$1.41M ﹤0.01% 1633
2022
Q1
$2.21M Buy
27,728
+775
+3% +$57.7K ﹤0.01% 1453
2021
Q4
$2.46M Buy
+26,953
New +$2.89M ﹤0.01% 1441

Other funds holding STAA

Allspring Global Investments's STAA Position: Q4 2023 in Review

Allspring Global Investments sold out of STAAR Surgical (STAA) in Q4 2023, closing a stake of 4,923 shares — an estimated $198K sold.

Allspring Global Investments first reported a position in STAA in Q4 2021 and held it in 8 quarters. The position peaked at $2.46M in Q4 2021. 207 funds tracked by Wall St. Rank hold STAA as of Q4 2023.

  • Allspring Global Investments reported no remaining STAAR Surgical position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 4,923 STAAR Surgical shares in Q4 2023, an estimated $198K.
  • Allspring Global Investments first reported a position in STAAR Surgical in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's STAAR Surgical position peaked at $2.46M in Q4 2021.
  • 207 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.